Flavagline derivatives to inhibit the activation of a KRAS oncogene

MA53902AUndetermined Publication Date: 2021-08-25KHR BIOTEC GMBH

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA53902
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2018-10-16
Filing Date: 2019-10-15
Publication Date: 2021-08-25

Application Information

Patent Timeline

16 Oct 2018

Priority

15 Oct 2019

Application

MA53902

25 Aug 2021

Publication

MA53902A

IPC: A61K31/343; A61P35/00

CPC: A61K31/343; A61P43/00; A61P35/00; C07D307/93

Inventors: RAJALINGAM Krishnaraj; YURUGI Hajime

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.